Incyte to Present New Data Highlighting Progress Across its Dermatology Pipeline at the European Association of Dermatology and Venerology 2025 Congress Biotech Investing
Arrowhead Pharmaceuticals Requests Regulatory Clearance to Initiate Phase 1/2a Study of ARO-MAPT for the Treatment of Alzheimer's Disease and Other Tauopathies Biotech Investing
PMV Pharmaceuticals Announces Promising Rezatapopt Monotherapy Interim Data From PYNNACLE Phase 2 Trial Across Multiple Solid Tumors With a TP53 Y220C Mutation Biotech Investing
Instil Bio Announces ImmuneOnco's Presentation of '2510 Monotherapy Data in Patients with 2L+ Squamous NSCLC at the 2025 World Conference on Lung Cancer Biotech Investing
Avidity Biosciences' Del-zota Demonstrated Reversal of Disease Progression Across Key Functional Endpoints in EXPLORE44® and EXPLORE44-OLE Phase 1/2 Trial in People Living with DMD44 Biotech Investing
HCW Biologics Reports Positive Results from Non-Human Primate Study for Its Proprietary Second-Generation T-Cell Engager Program Biotech Investing
Cizzle Brands Launches HappiEats Sport Pasta, a Premium High Protein, Lower Glycemic Index Pasta Designed for Athletes of All Ages Biotech Investing
Cizzle Brands Launches HappiEats Sport Pasta, a Premium High Protein, Lower Glycemic Index Pasta Designed for Athletes of All Ages Biotech Investing
Anavex Life Sciences Announces Oral Blarcamesine Cognitive Resilience Results Approximating Normal Aging in New Precision Medicine Clinical Data from Phase IIb/III Alzheimer's Disease Trial Biotech Investing
